MedTrace Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
44
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$19.7M
- Investors
-
14
MedTrace General Information
Description
Developer of medical devices designed to offer novel safety features to revolutionize blood flow imaging in PET. The company's platform offers an automated on-site production and infusion system for water in the scanner suite to innovate diagnostic imaging by transforming blood flow quantification, enabling physicians to get a platform that assists in focusing on heart-study applications, and brain and tumor vascularization.
Contact Information
Website
www.medtracepharma.comCorporate Office
- Agern Allé 5A
- 2970 Hørsholm
- Denmark
Corporate Office
- Agern Allé 5A
- 2970 Hørsholm
- Denmark
MedTrace Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC (Series C) | 21-Sep-2023 | $19.7M | Completed | Clinical Trials - Phase 3 | ||
| 11. Later Stage VC | 24-May-2022 | Completed | Clinical Trials - Phase 3 | |||
| 10. Later Stage VC (Series B) | 11-May-2021 | Completed | Clinical Trials - Phase 3 | |||
| 9. Later Stage VC | 08-Apr-2020 | Completed | Clinical Trials - Phase 3 | |||
| 8. Grant | 01-Mar-2020 | Completed | Startup | |||
| 7. Early Stage VC | 03-Jul-2019 | Completed | Pre-Clinical Trials | |||
| 6. Angel (individual) | 10-Mar-2017 | Completed | Startup | |||
| 5. Accelerator/Incubator | 01-Jan-2016 | Completed | Pre-Clinical Trials | |||
| 4. Grant | 14-Dec-2015 | $389K | Completed | Pre-Clinical Trials | ||
| 3. Early Stage VC | 01-Sep-2015 | Completed | Pre-Clinical Trials |
MedTrace Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 187,944 | $7.68 | $7.68 | 1x | $7.68 | 4.14% | ||
| Ordinary | 125,489 | $6.14 | $6.14 | 1x | $6.14 | 2.76% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
MedTrace Comparisons
Industry
Financing
Details
MedTrace Competitors (3)
One of MedTrace’s 3 competitors is Ionetix, a Formerly VC-backed company based in Lansing, MI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ionetix | Formerly VC-backed | Lansing, MI | ||||
| HeartFlow | Formerly VC-backed | Mountain View, CA | ||||
| Blue Earth Therapeutics | Venture Capital-Backed | Oxford, United Kingdom |
MedTrace Patents
MedTrace Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018115286-A1 | An infusion system for short-lived radiopharmaceuticals | Inactive | 21-Dec-2016 | ||
| US-20200085977-A1 | Diagnostic usages of short-lived radiopharmaceuticals | Active | 21-Dec-2016 | ||
| WO-2018115299-A1 | Diagnostic usages of short-lived radiopharmaceuticals | Inactive | 21-Dec-2016 | ||
| JP-2020514265-A | Diagnostic use of short-lived radiopharmaceuticals | Active | 21-Dec-2016 | ||
| JP-2020501827-A | Infusion system for short-lived radiopharmaceuticals | Active | 21-Dec-2016 | A61M5/007 |
MedTrace Signals
MedTrace Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTravest | Venture Capital | Minority | ||
| Oceanventures | Venture Capital | Minority | ||
| BankInvest Group | Asset Manager | Minority | ||
| Swisscanto Holding | Asset Manager | Minority | ||
| The ATP Group | Limited Partner | Minority |
MedTrace Acquisitions (1)
MedTrace’s most recent deal was a Merger/Acquisition with aQuant (Outcome Management (Healthcare)). The deal was made on 01-Jan-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| aQuant (Outcome Management (Healthcare)) | 01-Jan-2018 | Merger/Acquisition | Outcome Management (Healthcare) |
MedTrace FAQs
-
When was MedTrace founded?
MedTrace was founded in 2015.
-
Where is MedTrace headquartered?
MedTrace is headquartered in Hørsholm, Denmark.
-
What is the size of MedTrace?
MedTrace has 44 total employees.
-
What industry is MedTrace in?
MedTrace’s primary industry is Diagnostic Equipment.
-
Is MedTrace a private or public company?
MedTrace is a Private company.
-
What is the current valuation of MedTrace?
The current valuation of MedTrace is .
-
What is MedTrace’s current revenue?
The current revenue for MedTrace is .
-
How much funding has MedTrace raised over time?
MedTrace has raised $71.2M.
-
Who are MedTrace’s investors?
MedTravest, Oceanventures, BankInvest Group, Swisscanto Holding, and The ATP Group are 5 of 14 investors who have invested in MedTrace.
-
Who are MedTrace’s competitors?
Ionetix, HeartFlow, and Blue Earth Therapeutics are competitors of MedTrace.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process